Abstract:Stroke, Ahead of Print. BACKGROUND:Previous studies yielded conflicting results about the influence of blood pressure (BP) and antihypertensive treatment on cerebral small vessel disease. Here, we conducted a Mendelian randomization study to investigate the effect of BP and antihypertensive drugs on cerebral small vessel disease.METHODS:We extracted single-nucleotide polymorphisms for systolic BP and diastolic BP from a genome-wide association study (N=757 601) and screened single-nucleotide polymorphisms associated with calcium channel blockers, thiazides, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and β-blockers from public resources as instrumental variables. Then, we chose the genome-wide association study of white matter hyperintensity (WMH; N=18 381), cerebral microbleed (3556 cases, 22 306 controls), white matter perivascular space (9317 cases, 29 281 controls), basal ganglia perivascular space (BGPVS; 8950 cases, 29 953 controls), hippocampal perivascular space (HIPPVS; 9163 cases, 29 708 controls), and lacunar stroke (6030 cases, 248 929 controls) as outcome data sets. Subsequently, we conducted a 2-sample Mendelian randomization analysis.RESULTS:We found that elevated systolic BP significantly increases the risk of BGPVS (odds ratio [OR], 1.05 [95% CI, 1.04–1.07];P=1.72×10−12), HIPPVS (OR, 1.04 [95% CI, 1.02–1.05];P=2.71×10−7), and lacunar stroke (OR, 1.41 [95% CI, 1.30–1.54];P=4.97×10−15). There was suggestive evidence indicating that elevated systolic BP is associated with higher WMH volume (β=0.061 [95% CI, 0.018–0.105];P=5.58×10−3) and leads to an increased risk of cerebral microbleed (OR, 1.16 [95% CI, 1.04–1.29];P=7.17×10−3). Elevated diastolic BP was significantly associated with higher WMH volume (β=0.087 [95% CI, 0.049–0.124];P=5.23×10−6) and significantly increased the risk of BGPVS (OR, 1.05 [95% CI, 1.04–1.06];P=1.20×10−16), HIPPVS (OR, 1.03 [95% CI, 1.02–1.04];P=2.96×10−6), and lacunar stroke (OR, 1.31 [95% CI, 1.21–1.41];P=2.67×10−12). The use of calcium channel blocker to lower BP was significantly associated with lower WMH volume (β=−0.287 [95% CI, −0.408 to −0.165];P=4.05×10−6) and significantly reduced the risk of BGPVS (OR, 0.85 [95% CI, 0.81–0.89];P=8.41×10−19) and HIPPVS (OR, 0.88 [95% CI, 0.85–0.92];P=6.72×10−9).CONCLUSIONS:Our findings contribute to a better understanding of the pathogenesis of cerebral small vessel disease. Additionally, the utilization of calcium channel blockers to decrease BP can effectively reduce the likelihood of WMH, BGPVS, and HIPPVS. These findings offer valuable insights for the management and prevention of cerebral small vessel disease.

Linear and Nonlinear Mendelian Randomization Analyses of the Association Between Diastolic Blood Pressure and Cardiovascular Events

Abstract 16532: Impact of Systolic Blood Pressure on Cardiovascular Disease in a Chinese Population: A Mendelian Randomization Study

Assessing Causal Estimates of the Association of Obesity-Related Traits with Coronary Artery Disease Using a Mendelian Randomization Approach

The Association of Arterial Stiffness Index with Cerebrovascular and Cardiometabolic Disease: A Mendelian Randomization Study

Investigating Genetic Causal Relationships Between Blood Pressure and Anxiety, Depressive Symptoms, Neuroticism and Subjective Well-Being

Causal effect of hypertension and blood pressure on aortic diseases: evidence from Mendelian randomization

Effect of the Blood Pressure and Antihypertensive Drugs on Cerebral Small Vessel Disease: A Mendelian Randomization Study

Mendelian Randomization Study of Obesity and Cerebrovascular Disease

Research Letter: Genetically determined blood pressure traits are associated with increased risk of aortic dissection: a Mendelian randomization study

Genetically Predicted Differences in Systolic Blood Pressure and Risk of Cardiovascular and Noncardiovascular Diseases: A Mendelian Randomization Study in Chinese Adults

Investigating linear and nonlinear associations of LDL cholesterol with incident chronic kidney disease, atherosclerotic cardiovascular disease and all-cause mortality: A prospective and Mendelian randomization study

Major lipids and lipoprotein levels and risk of blood pressure elevation: a Mendelian Randomisation study

Assessing the Role of Blood Pressure in Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study

PM2.5 associates with blood pressure: a Mendelian randomization analysis

Genome-wide pleiotropy analysis identifies novel blood pressure variants and improves its polygenic risk scores

Causal effects of blood pressure and the risk of frailty: a bi-directional two-sample Mendelian randomization study

Genetically Determined Blood Pressure, Antihypertensive Medications, and Risk of Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage: A Mendelian Randomization Study

Type 2 Diabetes, Circulating Metabolites, and Calcific Aortic Valve Stenosis: A Mendelian Randomization Study

A Multivariable Mendelian Randomization Study of Systolic and Diastolic Blood Pressure, Lipid Profile, and Heart Failure Subtypes

Diastolic and systolic blood pressure and gout: a Mendelian randomization study

Association of plasma polyunsaturated fatty acids with arterial blood pressure A Mendelian randomization study